Navigation Links
3SBio Announces Investor Conference Schedule
Date:9/7/2010

3SBio Announces Investor Conference Schedule -- re> SHENYANG, China, Sept. 7 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Supplementary Medicine, Trade Show News Click to view news release full screen  

3SBio Announces Investor Conference Schedule

 

SHENYANG, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products today announced its planned participation in the following investor conferences: Sep 9-10, 2010 Susquehanna Fourth Annual Beijing Management Summit Beijing Sep 13-14, 2010 Morgan Stanley Global Healthcare Conference NYC Oct 20-22, 2010 Citigroup Greater China Investor Conference Macau Nov 1-2, 2010 Goldman Sachs China Investment Frontier Conference Beijing Nov 3-5, 2010 Bank of America Merrill Lynch China Investment Summit Beijing Nov 9-11, 2010 Morgan Stanley Asia Pacific Summit 2010 Singapore

Please see http://bbs.3sbio.com/en/News/xShowInfo_nnn6.aspx?ID=65 for further updates.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 500 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see http://www.3SBio.com for more information.

For more information, please contact: Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: +852-8191-6991 Email: ir@3SBio.com
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
2. 3SBio Inc. Announces Results of Annual General Meeting
3. China-Biotics Announces September 20 Investor Day Schedule
4. AcuNetx Announces Change in Trading Status
5. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
6. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
7. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
8. Nutraceutical Leader Announces Internal Promotions of Key Personnel
9. United American Healthcare Corporation Announces Increase in Board Size and New Director Nominees
10. Ellman International Announces Executive Team Hire
11. Yongye International Announces RMB 400 Million Revolving Credit Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... 2017 , ... “The Trials I Face to Receive God’s Grace”: a ... aspirations and goals to better one’s life through God. “The Trials I Face to ... all the wrong places, found a love for writing. Green feels that expressing his ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... gathering of executive marketers this week about the value of senior executives, pointed ... that has happened in business has brought us to the present and will ...
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her Funeral”: a ... murderer starts revealing the skeletons in their closets. “They Sang At Her Funeral” is ... fifty-six years young and married with five children and twelve grandchildren. Before becoming a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... addition of strategic marketing leader, Denise Flannery, to its strategic advisory and client ... Management Consultant, Denise will work with clients across different industries to develop and ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... that Scott McFarland has joined its executive team as the President of ... innovative value-based care management systems and contact centers. , “Scott is a ...
Breaking Medicine News(10 mins):